FBXW7 and DNA copy number instability

被引:0
|
作者
Kristin N. Byrd
Bing Huey
Ritu Roydasgupta
Jane Fridlyand
Antoine M. Snijders
Donna G. Albertson
机构
[1] University of California San Francisco,Cancer Research Institute
[2] University of California San Francisco,Comprehensive Cancer Center
[3] University of California San Francisco,Department of Laboratory Medicine
[4] University of California San Francisco,Department of Epidemiology and Biostatistics
来源
关键词
Genome instability; Array CGH;
D O I
暂无
中图分类号
学科分类号
摘要
SKP1-cullin-F-box protein (SCF) type ubiquitin ligases degrade proteins controlling the G1/S transition. Deficiency for FBXW7 (also known as hCDC4), which encodes the F-box protein of the SCF type ubiquitin ligase is associated with genomic instability. Here, we investigated the association of FBXW7 deficiency with chromosomal instability in breast cancer. We screened 49 tumors previously profiled by array CGH for mutations in conserved regions of FBXW7, but found no mutations. Copy number loss of FBXW7, however was associated with enhanced genomic instability in the Complex breast tumor subtype, but instability may not be due to FBXW7 haploinsufficiency, since transcript levels were not reduced in tumors with loss of the locus, whereas reduced expression was observed for other neighboring genes involved in maintenance of genome stability. We also investigated whether cells deficient for FBXW7 showed enhanced instability by challenging cells with methotrexate and assessing numbers of genomic alterations arising in resistant cells. Although methotrexate resistant colonies formed at high frequencies in HCT116 FBXW7+/− and HCT116 FBXW7−/− cells compared to parental HCT116, few copy number alterations were detected in the resistant cells. Taken together these studies suggest that FBXW7 deficiency is unlikely to contribute to the extensive copy number aberrations associated with breast and possibly other tumor types.
引用
收藏
页码:47 / 54
页数:7
相关论文
共 50 条
  • [21] The role of FBXW7 as a predictor of imatinib resistance for GIST
    Wu, Xiyu
    Iwatsuki, Masaaki
    Baba, Hideo
    Lou, Meiyue
    Ishimoto, Takatsugu
    Baba, Yoshifumi
    Miyamoto, Yuji
    CANCER SCIENCE, 2023, 114 : 1847 - 1847
  • [22] FBXW7 Mutations in Melanoma and a New Therapeutic Paradigm
    Aydin, Iraz T.
    Melamed, Rachel D.
    Adams, Sarah J.
    Castillo-Martin, Mireia
    Demir, Ahu
    Bryk, Diana
    Brunner, Georg
    Cordon-Cardo, Carlos
    Osman, Iman
    Rabadan, Raul
    Celebi, Julide Tok
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06):
  • [23] FBXW7 polymorphism asserts susceptibility to colorectal cancer
    Uroog, Laraib
    Zeya, Bushra
    Imtiyaz, Khalid
    Wani, Rauf Ahmad
    Rizvi, M. Moshahid Alam
    GENE, 2024, 901
  • [24] Exploring Fbxw7 regulation of Myrf in CNS myelination
    Collins, H. Y.
    GLIA, 2023, 71 : E795 - E795
  • [25] FBXW7: a critical tumor suppressor of human cancers
    Yeh, Chien-Hung
    Bellon, Marcia
    Nicot, Christophe
    MOLECULAR CANCER, 2018, 17
  • [26] The FBXW7 β-form is suppressed in human glioma cells
    Gu, Zhaodi
    Inomata, Kenichi
    Ishizawa, Kota
    Horii, Akira
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 354 (04) : 992 - 998
  • [27] Fbxw7 Limits Myelination by Inhibiting mTOR Signaling
    Kearns, Christina A.
    Ravanelli, Andrew M.
    Cooper, Kirsten
    Appel, Bruce
    JOURNAL OF NEUROSCIENCE, 2015, 35 (44): : 14861 - 14871
  • [28] FBXW7 circular RNA repress glioma tumorigenesis
    Pinto, Mariana Tomazini
    Reis, Rui Manuel
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S558 - S561
  • [29] Recent insight into the role of FBXW7 as a tumor suppressor
    Yumimoto, Kanae
    Nakayama, Keiichi I.
    SEMINARS IN CANCER BIOLOGY, 2020, 67 : 1 - 15
  • [30] FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs
    Yokobori, Takehiko
    Yokoyama, Yozo
    Mogi, Akira
    Endoh, Hideki
    Altan, Bolag
    Kosaka, Takayuki
    Yamaki, Ei
    Yajima, Toshiki
    Tomizawa, Kenji
    Azuma, Yoko
    Onozato, Ryoichi
    Miyazaki, Tatsuya
    Tanaka, Shigebumi
    Kuwano, Hiroyuki
    MOLECULAR CANCER RESEARCH, 2014, 12 (01) : 32 - 37